Aerostability of Sin Nombre Virus Aerosol Related to Near-Field Transmission

Elizabeth A Klug1,2, Danielle N Rivera2, Vicki L Herrera1,2

  • 1Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USA.

PubMed

Insights

Sin Nombre virus (SNV) bioaerosols are inactivated by simulated solar radiation and ozone. Understanding SNV decay profiles is key to preventing hantavirus cardiopulmonary syndrome (HCPS) transmission.

Area of Science:

  • Environmental Virology
  • Aerosol Science
  • Public Health

Background:

  • Sin Nombre virus (SNV) causes hantavirus cardiopulmonary syndrome (HCPS) in North America.
  • SNV spreads through infectious biological aerosols (bioaerosols) from infected deer mice (Peromyscus maniculatus).
  • Environmental transmission routes, like SNV, pose significant public health challenges despite lacking person-to-person spread.

Purpose of the Study:

  • To investigate the decay profile of SNV bioaerosols under various environmental conditions.
  • To determine the susceptibility of SNV bioaerosols to simulated solar radiation (SSR) and ozone.
  • To inform preventative strategies against SNV infections.

Main Methods:

  • Utilized the Biological Aerosol Reaction Chamber (Bio-ARC) to expose SNV bioaerosols to controlled environmental factors.
  • Assessed SNV decay rates when aerosolized in residual media and a mouse bedding matrix.
  • Measured the impact of SSR and ozone on SNV bioaerosol stability.

Main Results:

  • SNV bioaerosols demonstrated susceptibility to both simulated solar radiation and ozone.
  • The decay rates of SNV were similar whether aerosolized in residual media or mouse bedding.
  • SNV aerosol particles are inactivated by solar radiation and ozone under tested conditions.

Conclusions:

  • Solar radiation and ozone are effective agents for inactivating SNV bioaerosols.
  • These findings can guide the development of control measures for SNV in endemic areas.
  • Implementing UV disinfection and ozone treatments could mitigate HCPS risk.